Other clinicopathological parameters analyzed in the study were patient survival, tumor location, and histology according to mRNA expression, and it was noted that a high CD44 level in hepatic metastases was associated with a lower survival rate than in patients with low expression levels and all the other factors. The gene discussed is CD44; the disease is neoplasm.